Researchers reviewed data from 201 patients diagnosed with head and neck squamous cell carcinoma who later developed brain metastases. These patients were treated at three tertiary care institutions. The study compared those who received local brain treatments, such as whole-brain radiotherapy, stereotactic radiosurgery, or surgery with post-operative radiotherapy, against those who received no treatment.
The main finding was that patients receiving local therapy had a lower risk of death compared to those who did not receive treatment. Specifically, those treated with radiotherapy alone had a hazard ratio of 0.72, while those undergoing surgery with radiotherapy had a hazard ratio of 0.64. Despite these associations, the incidence of brain metastasis in this group was low, at 1.1%.
The median survival time after a brain metastasis diagnosis was three months, and all patients succumbed within two years. The distribution of metastases varied, with most located in the supratentorial region. No safety concerns or adverse events were reported in this retrospective analysis. Readers should understand that this is an observational study, meaning it shows links but does not prove that the treatments caused the survival benefit. Because the condition is rare and the sample size is small, these results may not apply to all patients.
